A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulations

JP Barrett; KA Vardulaki; C Conlon; J Cooke; P Daza-Ramirez; EG Evans; Peter Hawkey; R Herbrecht; DI Marks; JM Moraleda; GR Park; SJ Senn; C Viscoli

doi:10.1016/S0149-2918(03)80125-X

A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulations

JP Barrett
, KA Vardulaki
, C Conlon
, J Cooke
, P Daza-Ramirez
, EG Evans
, Peter Hawkey
, R Herbrecht
, DI Marks
, JM Moraleda
, GR Park
, SJ Senn
, C Viscoli

Immunology and Immunotherapy

Research output: Contribution to journal › Review article

140 Citations (Scopus)

Original language	English
Pages (from-to)	1295-320
Number of pages	26
Journal	Clinical Therapeutics
Volume	25
DOIs	https://doi.org/10.1016/S0149-2918(03)80125-X
Publication status	Published - 1 May 2003

Access to Document

10.1016/S0149-2918(03)80125-X

Cite this

@article{18cf3bdc81e0442eb14562276bfb326a,

title = "A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulations",

author = "JP Barrett and KA Vardulaki and C Conlon and J Cooke and P Daza-Ramirez and EG Evans and Peter Hawkey and R Herbrecht and DI Marks and JM Moraleda and GR Park and SJ Senn and C Viscoli",

year = "2003",

month = may,

day = "1",

doi = "10.1016/S0149-2918(03)80125-X",

language = "English",

volume = "25",

pages = "1295--320",

journal = "Clinical Therapeutics",

publisher = "Elsevier",

}

TY - JOUR

T1 - A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulations

AU - Barrett, JP

AU - Vardulaki, KA

AU - Conlon, C

AU - Cooke, J

AU - Daza-Ramirez, P

AU - Evans, EG

AU - Hawkey, Peter

AU - Herbrecht, R

AU - Marks, DI

AU - Moraleda, JM

AU - Park, GR

AU - Senn, SJ

AU - Viscoli, C

PY - 2003/5/1

Y1 - 2003/5/1

UR - https://www.scopus.com/pages/publications/0038282815

U2 - 10.1016/S0149-2918(03)80125-X

DO - 10.1016/S0149-2918(03)80125-X

M3 - Review article

C2 - 12867214

VL - 25

SP - 1295

EP - 1320

JO - Clinical Therapeutics

JF - Clinical Therapeutics

ER -